Volltextsuche nutzen

B O O K SCREENER

Aktuelle Veranstaltungen

Events
  • versandkostenfrei ab € 30,–
  • 6x in Wien und Salzburg
  • 6 Mio. Bücher
Menü
Leading Pharmaceutical Innovation

Leading Pharmaceutical Innovation

How to Win the Life Science Race

Leading Pharmaceutical Innovation
Hardcover
87,99
inkl. gesetzl. MwSt.
Herstellung bei AnforderungVersandkostenfreibestellen in Österreich
Deutschland: € 10,00
EU & Schweiz: € 20,00
In den Warenkorb
Click & Collect
Artikel online bestellen und in der Filiale abholen.
Artikel in den Warenkorb legen, zur Kassa gehen und Wunschfiliale auswählen. Lieferung abholen und bequem vor Ort bezahlen.
Derzeit in keiner facultas Filiale lagernd. Jetzt online bestellen!
Auf die Merkliste

Veröffentlicht 2018, von Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer bei Springer International Publishing

ISBN: 978-3-319-66832-1
Auflage: 3. Auflage
XV, 179 Seiten
XV, 179 p. 41 illus., 3 illus. in color.
23.5 cm x 15.5 cm

 




...
Beschreibung
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

Über Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer



Prof. Dr.
Oliver Gassmann
is professor of technology management at the University of St. Gallen (Switzerland), and managing director of the Institute of Technology Management. After completing his PhD in 1996, he was head of corporate research at Schindler. He published over 400 papers in leading international management journals. In 2014, he was awarded the Scholary Impact Award by the Journal of Management, and in 2015 with the Citation Excellence Award of the Emerald Group. He also serves as a founder and advisor on several boards.




Prof. Dr.
Alexander Schuhmacher
is professor at Reutlingen University (Germany). He teaches in business management and medical science. He officiates as Senator of Reutlingen University and he also serves as managing director of the Knowledge Foundation @ Reutlingen University. He worked for 14 years in various R&D positions in the pharmaceutical industry. As member of Nycomed’s senior R&D management team, he headed the StrategicPlanning & Business Support function and co-headed the R&D integration team following the merger of Nycomed and ALTANA Pharma.




Prof. Dr.
Max von Zedtwitz
is professor at Kaunas University of Technology (Lithuania), and director of the GLORAD Center for Global R&D and Innovation. Previously he was a professor at Tsinghua, Peking University, Skoltech, and IMD, and a vice president at PRTM. In 2009 he was recognized by IAMOT as one of the fifty most influential innovation scholars worldwide. A frequent public speaker, he has appeared on television, and has been cited in the Economist, China Daily, the South China Morning Post and the New York Times.




Dr.
Gerrit Reepmeyer
is co-founder & COO of Guardhat Inc., a startup based in Detroit (USA). Prior to that, he held various executive leadership positions in industrial and technology companies. He started his career in management consulting with McKinsey & Company. He has a PhD degree from the University of St. Gallen and was a research scholar at Columbia University in New York. He co-authored several books and publications on technology management, and he is co-inventor of five patents.